MAHZI THERAPEUTICS INC.

Profile

Company Names

MAHZI THERAPEUTICS INC.

Addresses

470 NOOR AVE, STE B, #1036, SOUTH SAN FRANCISCO, CA 94080

205 MONTE DIABLO AVENUE, #4C, SAN MATEO, CA 94401

Phone Numbers

415-627-8781

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$52,586,424.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-10-07 
$52,586,424.00 
$52,586,424.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
FARR 
DIRECTOR
STEADYMED LTD.   |  CEREBRAL THERAPEUTICS, INC.   |  FLOW PHARMA, INC.   |  MAHZI THERAPEUTICS INC.
CAMILLE 
 
SAMUELS 
DIRECTOR
SEMPRAE LABORATORIES INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  ACHAOGEN INC   |  SPIROX, INC.   |  REGENXBIO INC.   |  UNITY BIOTECHNOLOGY, INC.   |  BIOLUX RESEARCH HOLDINGS, INC.   |  XCALIBER BIOTECHNOLOGY, INC.   |  OCELOT BIO, INC.   |  MAHZI THERAPEUTICS INC.
SHALINI 
 
SHARP 
DIRECTOR
ANTIGENICS INC /DE/   |  ULTRAGENYX PHARMACEUTICAL INC.   |  AGENUS INC   |  PRECISION BIOSCIENCES INC   |  MAHZI THERAPEUTICS INC.   |  IAMBIC THERAPEUTICS, INC.
MARTEN 
 
STEEN 
DIRECTOR
FERROKIN BIOSCIENCES INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  HEALTHCAP VI, L.P.   |  CORTENDO AB   |  VAXIN INC.   |  STRONGBRIDGE BIOPHARMA PLC   |  HEALTHCAP VII, L.P.   |  BIOCLIN THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.   |  ARO BIOTHERAPEUTICS CO   |  MAHZI THERAPEUTICS INC.
YAEL 
 
WEISS 
EXECUTIVE OFFICER, DIRECTOR
MAHZI THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-07-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-07 
2022-11-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-07 
2021-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#